Coronary Intervention Outcomes in Patients with Liver Cirrhosis
2024

Coronary Intervention Outcomes in Patients with Liver Cirrhosis

Sample size: 7000 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ang Song Peng, Chia Jia Ee, Iglesias Jose, Usman Muhammed Haris, Krittanawong Chayakrit

Primary Institution: Rutgers Health/Community Medical Center

Hypothesis

What are the outcomes of coronary interventions in patients with liver cirrhosis and coronary artery disease?

Conclusion

Patients with liver cirrhosis undergoing coronary interventions face significantly higher mortality rates and complications compared to non-cirrhotic patients.

Supporting Evidence

  • Patients with liver cirrhosis have higher in-hospital mortality rates during PCI compared to non-cirrhotic patients.
  • Radial access is recommended to reduce bleeding complications in cirrhotic patients undergoing PCI.
  • Contrast-induced nephropathy is a significant risk for cirrhotic patients post-PCI.

Takeaway

People with liver cirrhosis who need heart procedures are at a much higher risk of dying or having problems than those without liver issues.

Methodology

This review assesses outcomes based on recent studies and databases comparing patients with and without liver cirrhosis undergoing PCI.

Potential Biases

Potential biases may arise from the retrospective nature of the studies reviewed.

Limitations

The study primarily relies on retrospective data, which may not capture all variables affecting outcomes.

Participant Demographics

The study includes patients with liver cirrhosis and coronary artery disease, with varying severity of liver disease.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 1.28–1.41

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s11886-024-02163-x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication